Delivery Order SPE2DR25D2216-SPE2DR26F7UL0
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, for the supply of Nucynta ER Tablets 100mg with a ceiling value of $12,560.28. The competitively awarded, firm fixed-price delivery order is funded by the Defense Department's Medical Supply Chain and is due for completion by November 26, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order for Nucynta ER Tabs 250mg valued at $12,666.01 by the Defense Department's Medical Supply Chain on October 28, 2025, with an ultimate completion date of October 29, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 3, 2025, for the supply of Nucynta ER 150 mg tablets (60-count). The contract is competitively awarded with no set-aside designation and carries a ceiling value of $2,817.62 under a firm fixed-price arrangement. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency (DLA) for the supply of NUCYNTA ER 100 MG tablets (60-count packages) with a ceiling value of $9,298.18. The contract employs firm fixed price terms and is not subject to any set-aside designation, indicating competitive award status. This delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,654.48 by the Defense Logistics Agency Medical Supply Chain for the supply of Nucynta ER 50 mg tablets (60-count units). This firm fixed-price contract, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a non-competitive set-aside award. The contract will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Nucynta ER is a long-acting opioid pain...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Nucynta Tabs 50mg valued at $4,442.48 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on October 23, 2025. The contract is non-competitive, non-set-aside, and represents a single delivery order with an ultimate completion date of October 24, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,137.68 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a competitive procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- SPE2DR25D2216Indefinite Delivery Contract
- SPE2DR25D2216-SPE2DR26F7UL0Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on December 11, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a ceiling value of $1,156.26. The contract is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 12, 2025. This award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a substantial $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and U.S. Coast Guard healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, the company has demonstrated extensive capability in fulfilling federal medical supply needs across multiple therapeutic domains through consistently competitive awards. The company's federal contract portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies, positioning it as a key supplier within the military's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/10/25 |